Riskpilot← Back to searchSign inGet full accessAPOTEK RINGNES PARK SENTER AS
ASActiveOrg 916179480Sannergata 6, 0557 OsloRetail sale of pharmaceutical products · NACE 4773Est. 201528 employees
Revenue 2024
NOK 39,7M
+20% vs 2023
EBITDA margin
6.9%
+40% vs 2023
Equity ratio
45.0%
Financial strength
Net profit 2024
NOK 1,8M
+46% vs 2023
| Revenue | NOK 39,7M | +20% |
| EBITDA | NOK 2,7M | +40% |
| Net profit | NOK 1,8M | +46% |
| Total assets | NOK 11,1M | -14% |
| Equity | NOK 5M | +19% |
| Employees | 28 | — |
Legal name
APOTEK RINGNES PARK SENTER AS
Org number
916179480
Legal form
Aksjeselskap
NACE code
4773 · Retail sale of pharmaceutical products
Founded
5. november 2015
Share capital
NOK 30 000
Employees
28 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets leder alene.
Company purpose
Eie og drive apotek, herunder konsulenttjenester innenfor apotekerbransjen og lege- og helserelaterte produkter, samt øvrig virksomhet i tilknytning til dette.
Address
Sannergata 6, 0557 Oslo
Phone
+4722686100
Email
apotek1.ringnespark@apotek1.no
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 23 805 | 25 980 | 27 908 | 33 049 | 39 706 |
| Staff expenses | −4 523 | −4 617 | −4 841 | −5 166 | −5 353 |
| EBITDA | 1 356 | 1 400 | 1 405 | 1 961 | 2 745 |
| Depreciation & amort. | −254 | −262 | −266 | −352 | −420 |
| EBIT | 1 102 | 1 138 | 1 139 | 1 609 | 2 325 |
| Net financials | 0 | −0 | −1 | −5 | −7 |
| Profit before tax | 1 103 | 1 137 | 1 138 | 1 604 | 2 318 |
| Tax | 243 | 261 | 255 | 369 | 514 |
| Net profit | 860 | 877 | 883 | 1 235 | 1 803 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 6 374 | 7 931 | 8 534 | 12 962 | 11 111 |
| Equity | 1 210 | 2 086 | 2 970 | 4 205 | 4 994 |
| Long-term debt | 1 860 | 1 913 | 1 884 | 1 262 | 0 |
| Short-term debt | 3 304 | 3 932 | 3 681 | 7 495 | 6 117 |
| Total debt | 5 165 | 5 845 | 5 565 | 8 757 | 6 117 |
EBITDA margin
6.9%
This company
15.8%
Market median
-56% vs market
20202024
Equity ratio
45.0%
This company
38.2%
Market median
+18% vs market
20202024
Return on equity
36.1%
This company
18.4%
Market median
+96% vs market
20202024
Net profit margin
4.5%
This company
8.1%
Market median
-44% vs market
20202024
Asset turnover
3.57×
This company
1.12×
Market median
+219% vs market
20202024
Debt / equity
1.22×
This company
0.62×
Market median
-97% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
VC Chief Executive Officer | Chief Executive Officer | 2015 |
TT Deputy Member | Deputy Member | 2015 |
No data on file.
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2022 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Nguyen-Doan Holding As
APOTEK RINGNES PARK SENTER AS Board members of APOTEK RINGNES PARK SENTER AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Vincent Cuong Nguyen-Doan | Chief Executive Officer | 0 companies |
| Therese Thu Huynh | Deputy Member | 0 companies |